Love Pharma Inc (TSE:JOLT) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jolt Health Inc. has canceled its arrangement to acquire a transdermal drug delivery technology and is redirecting its efforts to the artificial intelligence sector, aiming to drive innovation in healthcare. The company’s CEO expressed confidence in AI to strengthen their health and wellness offerings and is optimistic about recent interest rate cuts boosting the economy. Jolt Health maintains exclusive licenses for various therapeutic and pharmaceutical products across Europe, the UK, and North America.
For further insights into TSE:JOLT stock, check out TipRanks’ Stock Analysis page.